Compumedics Bilan de santé

Santé financière contrôle des critères 4/6

Compumedics possède un total de capitaux propres de A$18.2M et une dette totale de A$7.0M, ce qui porte son ratio d'endettement à 38.3%. Son actif total et son passif total sont A$40.4M et de A$22.1M.

Informations clés

38.3%

Ratio d'endettement

AU$6.98m

Dette

Ratio de couverture des intérêts	n/a
Argent liquide	AU$1.89m
Fonds propres	AU$18.21m
Total du passif	AU$22.15m
Total des actifs	AU$40.36m

Mises à jour récentes de la santé financière

Recent updates

This Is Why Compumedics Limited's (ASX:CMP) CEO Compensation Looks Appropriate

Oct 24

Further Upside For Compumedics Limited (ASX:CMP) Shares Could Introduce Price Risks After 38% Bounce

Jun 17

Returns On Capital Signal Difficult Times Ahead For Compumedics (ASX:CMP)

Mar 07

We Think Compumedics (ASX:CMP) Has A Fair Chunk Of Debt

Nov 03

Is Compumedics (ASX:CMP) A Risky Investment?

May 27

Compumedics (ASX:CMP) Could Be At Risk Of Shrinking As A Company

Jan 25

Some Shareholders May Object To A Pay Rise For Compumedics Limited's (ASX:CMP) CEO This Year

Oct 19

Compumedics (ASX:CMP) Seems To Use Debt Quite Sensibly

Oct 14

Is Compumedics (ASX:CMP) Using Debt Sensibly?

May 02

Compumedics (ASX:CMP) May Have Issues Allocating Its Capital

Dec 08

Compumedics (ASX:CMP) Will Want To Turn Around Its Return Trends

Aug 09

Here's Why Compumedics (ASX:CMP) Has A Meaningful Debt Burden

Jun 10

Returns On Capital Signal Tricky Times Ahead For Compumedics (ASX:CMP)

May 06

These 4 Measures Indicate That Compumedics (ASX:CMP) Is Using Debt Extensively

Feb 25

How Much Did Compumedics'(ASX:CMP) Shareholders Earn From Share Price Movements Over The Last Year?

Dec 01

Analyse de la situation financière

Passif à court terme: Les actifs à court terme de CMP ( A$26.2M ) dépassent ses passifs à court terme ( A$21.3M ).

Passif à long terme: Les actifs à court terme de CMP ( A$26.2M ) dépassent ses passifs à long terme ( A$896.0K ).

Historique et analyse du ratio d'endettement

Niveau d'endettement: Le ratio dette nette/capitaux propres de CMP ( 27.9% ) est considéré comme satisfaisant.

Réduire la dette: Le ratio d'endettement de CMP est passé de 5.7% à 38.3% au cours des 5 dernières années.

Couverture de la dette: La dette de CMP est bien couverte par le flux de trésorerie opérationnel ( 28.7% ).

Couverture des intérêts: Données insuffisantes pour déterminer si les paiements d'intérêts de CMP sur sa dette sont bien couverts par l'EBIT.

Compumedics Bilan de santé

Santé financière contrôle des critères 4/6

Informations clés

Mises à jour récentes de la santé financière

We Think Compumedics (ASX:CMP) Has A Fair Chunk Of Debt

Is Compumedics (ASX:CMP) A Risky Investment?

Compumedics (ASX:CMP) Seems To Use Debt Quite Sensibly

Is Compumedics (ASX:CMP) Using Debt Sensibly?

Here's Why Compumedics (ASX:CMP) Has A Meaningful Debt Burden

These 4 Measures Indicate That Compumedics (ASX:CMP) Is Using Debt Extensively

Recent updates

This Is Why Compumedics Limited's (ASX:CMP) CEO Compensation Looks Appropriate

Full year 2024 earnings released: AU$0.002 loss per share (vs AU$0.035 loss in FY 2023)

Compumedics Limited, Annual General Meeting, Oct 31, 2024

Full year 2024 earnings released: AU$0.001 loss per share (vs AU$0.035 loss in FY 2023)

New minor risk - Shareholder dilution

Further Upside For Compumedics Limited (ASX:CMP) Shares Could Introduce Price Risks After 38% Bounce

New minor risk - Share price stability

Returns On Capital Signal Difficult Times Ahead For Compumedics (ASX:CMP)

New major risk - Share price stability

We Think Compumedics (ASX:CMP) Has A Fair Chunk Of Debt

Full year 2023 earnings released: AU$0.035 loss per share (vs AU$0.008 profit in FY 2022)

Compumedics Limited, Annual General Meeting, Oct 31, 2023

Full year 2023 earnings released: AU$0.004 loss per share (vs AU$0.008 profit in FY 2022)

Compumedics Limited Provides Revenue Guidance for the Year 2023

Is Compumedics (ASX:CMP) A Risky Investment?

Compumedics Limited Re-Affirms Earnings Guidance for the Fiscal Year 2023

First half 2023 earnings released: AU$0.041 loss per share (vs AU$0.002 profit in 1H 2022)

Compumedics (ASX:CMP) Could Be At Risk Of Shrinking As A Company

Compumedics Limited Provides Revenue Guidance for the First Half of Fiscal Year 2023

No independent directors

Some Shareholders May Object To A Pay Rise For Compumedics Limited's (ASX:CMP) CEO This Year

Compumedics (ASX:CMP) Seems To Use Debt Quite Sensibly

Full year 2022 earnings released: EPS: AU$0.008 (vs AU$0.006 in FY 2021)

Compumedics Limited, Annual General Meeting, Oct 27, 2022

Full year 2022 earnings released: EPS: AU$0.008 (vs AU$0.006 in FY 2021)

Compumedics Limited Provides Revenue Guidance for the Fiscal Year 2023

Is Compumedics (ASX:CMP) Using Debt Sensibly?

No independent directors

Tucson Dunn Retires as Director of Compumedics Limited, Effective 31 March, 2022

First half 2022 earnings: EPS and revenues miss analyst expectations

Compumedics (ASX:CMP) May Have Issues Allocating Its Capital

Full year 2021 earnings released: EPS AU$0.006 (vs AU$0.033 loss in FY 2020)

Full year 2021 earnings released: EPS AU$0.006 (vs AU$0.033 loss in FY 2020)

Compumedics (ASX:CMP) Will Want To Turn Around Its Return Trends

Here's Why Compumedics (ASX:CMP) Has A Meaningful Debt Burden

Returns On Capital Signal Tricky Times Ahead For Compumedics (ASX:CMP)

New 90-day low: AU$0.41

These 4 Measures Indicate That Compumedics (ASX:CMP) Is Using Debt Extensively

First half 2021 earnings released: EPS AU$0.007 (vs AU$0.001 in 1H 2020)

How Much Did Compumedics'(ASX:CMP) Shareholders Earn From Share Price Movements Over The Last Year?

Price target lowered to AU$1.00

Compumedics Limited Announces Not to Provide Guidance for the Fiscal Year 2021

Compumedics Limited Announces That Sales Forecasts Will Remain Problematic Due to COVID-19 Pandemic

Analyse de la situation financière

Historique et analyse du ratio d'endettement

Bilan

Découvrir des entreprises saines